Skip to main content

Haynes named interim chair of Otolaryngology

Aug. 18, 2021, 3:04 PM


by Jill Clendening

David Haynes, MD

David Haynes, MD, has been named interim chair of the Department of Otolaryngology-Head and Neck Surgery (OHNS) effective July 1. He will serve in this role until Eben Rosenthal, MD, the John and Ann Doerr Medical Director and associate director of Clinical Care with Stanford Cancer Center, joins Vanderbilt University Medical Center as the department’s next chair on Oct. 11.

The chair’s role opened when Roland “Ron” Eavey, MD, announced that he would be stepping down from his position at the end of the 2021 academic year after serving as the department’s leader for 12 years.

“It is an honor to serve the department in this capacity as interim chair,” Haynes said. “As one of the top otolaryngology departments in the world, we are excited for the arrival of Eben Rosenthal, MD, in October and the skillset he brings in both the clinical and research enterprises.”

Haynes, holder of the Endowed Directorship in Otolaryngology for Relationship Development, is chief of the Division of Otology and Neurotology and director of the Neurotology Fellowship program. He is a professor of Otolaryngology, Neurosurgery and Hearing and Speech Sciences. He also serves as co-director of the Cochlear Implant Program and Skull Base Center.

Haynes is a graduate of the University of Tennessee College of Medicine and completed a fellowship in otology and neurotology at the Otology Group/the EAR Foundation, which is now the Otology Group at Vanderbilt. He is board certified in Otolaryngology and Neurotology and is a Fellow of the American College of Surgeons.

He has leadership positions in national organizations including executive boards of the American Neurotology Society, the Hearing Health Foundation, Otology and Neurotology Inc. and the American Cochlear Implant Alliance.

He is the associate editor of Otology and Neurotology Open. Haynes focuses his clinical practice on hearing restoration, cochlear implants and management skull base tumors.

His research interest includes optimizing health care delivery processes that has resulted in the Same Day Cochlear Implant Program, unique to VUMC, and the world’s first bundled cochlear implant program.

“I am so grateful that a faculty member with David’s talents has agreed to step into this role to provide a smooth transition,” Rosenthal said.

“With his expertise and extensive institutional knowledge, David is the ideal individual to continue to advance the department’s work in clinical care, research and education, which have all expanded significantly in the past several years.”

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice